Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Hansson

Showing results (121-130 of 199) with videos related to

Pageof 20
Sort By:
Genes, Chromosomes & Cancer|April 14, 2016
The role of germline alterations in the DNA damage response genes BRIP1 and BRCA2 in melanoma susceptibilityRainer Tuominen, Pär G Engström, Hildur Helgadottir, et al.
Acta Dermato-Venereologica|January 12, 2013
Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: impact on patient managementHanna Eriksson, Margareta Frohm-Nilsson, Mari-Anne Hedblad, et al.
Cancer Research|May 2, 2013
Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanismsYumeng Mao, Isabel Poschke, Erik Wennerberg, et al.
Oncoimmunology|September 17, 2020
PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidatesYago Pico de Coaña, Maria Wolodarski, Irene van der Haar Àvila, et al.
Melanoma Research|April 15, 2016
Prognostic and predictive value of YKL-40 in stage IIB-III melanomaMerete Krogh, Ib Christensen, Marna Bouwhuis, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
The prognostic role of blood lymphocyte subset distribution in patients with resected high-risk primary or regionally metastatic melanomaMicaela Hernberg, Petri S Mattila, Marjo Rissanen, et al.
World Journal of Urology|October 15, 2016
Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter reportRobert Rosenblatt, Markus Johansson, Farhood Alamdari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive programJohan Hansson, Mia Bergenmar, Per-Ake Hofer, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
Predicting anti-PD-1 responders in malignant melanoma from the frequency of S100A9+ monocytes in the bloodSoudabeh Rad Pour, Yago Pico de Coaña, Xavier Martinez Demorentin, et al.
Human Pathology|January 28, 2004
Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patientsPaola Ghiorzo, Barbara Villaggio, Angela Rita Sementa, et al.
Pageof 20

Showing results (121-130 of 199) with videos related to

Sort By:
Pageof 20
Genes, Chromosomes & Cancer|April 14, 2016
The role of germline alterations in the DNA damage response genes BRIP1 and BRCA2 in melanoma susceptibilityRainer Tuominen, Pär G Engström, Hildur Helgadottir, et al.
Acta Dermato-Venereologica|January 12, 2013
Interobserver variability of histopathological prognostic parameters in cutaneous malignant melanoma: impact on patient managementHanna Eriksson, Margareta Frohm-Nilsson, Mari-Anne Hedblad, et al.
Cancer Research|May 2, 2013
Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanismsYumeng Mao, Isabel Poschke, Erik Wennerberg, et al.
Oncoimmunology|September 17, 2020
PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidatesYago Pico de Coaña, Maria Wolodarski, Irene van der Haar Àvila, et al.
Melanoma Research|April 15, 2016
Prognostic and predictive value of YKL-40 in stage IIB-III melanomaMerete Krogh, Ib Christensen, Marna Bouwhuis, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 26, 2007
The prognostic role of blood lymphocyte subset distribution in patients with resected high-risk primary or regionally metastatic melanomaMicaela Hernberg, Petri S Mattila, Marjo Rissanen, et al.
World Journal of Urology|October 15, 2016
Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter reportRobert Rosenblatt, Markus Johansson, Farhood Alamdari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive programJohan Hansson, Mia Bergenmar, Per-Ake Hofer, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
Predicting anti-PD-1 responders in malignant melanoma from the frequency of S100A9+ monocytes in the bloodSoudabeh Rad Pour, Yago Pico de Coaña, Xavier Martinez Demorentin, et al.
Human Pathology|January 28, 2004
Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patientsPaola Ghiorzo, Barbara Villaggio, Angela Rita Sementa, et al.
Pageof 20